COO The Cooper Companies, Inc. - Common Stock
The Cooper Companies, Inc. - Common Stock 정보 위키백과 회사 개요
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.
더 보기
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.
History
Parker Montgomery, a lawyer, bought Martin H. Smith Co. in 1958. The company was renamed to Cooper, Tinsley Laboratories, Inc. in 1961. Its name was changed to Cooper Laboratories Inc. in 1967, and entered the contact lens business when it acquired British lens maker GlobalVision in 1972.
In 1980, Cooper Laboratories reorganized into three business groups: CooperVision, CooperCare and CooperBiomedical, with Cooper Medical Devices Corp. added as a fourth group one year later.
The company was renamed The Cooper Companies in 1987. Three years later, it was further restructured into three business units: CooperVision, CooperSurgical and CooperVision Pharmaceuticals (dissolved in 2003).
Currently, the firm operates as two business units: CooperVision and CooperSurgical. CooperVision serves contact lens wearers and eye care practitioners. Products include a range of daily, two-week and monthly disposable contact lenses, and other spherical, toric and multifocal lenses for astigmatism, nearsightedness and farsightedness, and presbyopia.
CooperSurgical is the medical device and fertility and genomics unit of the companies. It became a business unit in 1990 and its focus includes women's health and fertility. It is headquartered in Trumbull, Connecticut.
Acquisitions
Ocular Sciences Inc. was acquired by CooperVision in 2005.
CooperSurgical acquired AEGEA Medical, a medical manufacturing company in February 2021. A month later, in March, the company acquired Safe Obstetric Systems, and in December 2021, CooperSurgical acquired Generate Life Sciences for $1.6 billion.
In March 2022, CooperSurgical acquired Cook Medical's reproductive health business for $875 million. During that same year the company acquired EnsEyers, a supplier of orthokeratology and scleral contact lenses.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
COO 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
COO 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
배당금 배당 수익률, 지급 비율, 배당 이력, 5년 CAGR
| 배당락일 | 금액 |
|---|---|
| 2023년 7월 26일 | $0.0075 |
| 2023년 1월 20일 | $0.0075 |
| 2022년 7월 26일 | $0.0075 |
| 2022년 1월 20일 | $0.0075 |
| 2021년 7월 26일 | $0.0075 |
| 2021년 1월 21일 | $0.0075 |
| 2020년 7월 22일 | $0.0075 |
| 2020년 1월 22일 | $0.0075 |
| 2019년 7월 22일 | $0.0075 |
| 2019년 1월 18일 | $0.0075 |
| 2018년 7월 20일 | $0.0075 |
| 2018년 1월 22일 | $0.0075 |
| 2017년 7월 19일 | $0.0075 |
| 2017년 1월 19일 | $0.0075 |
| 2016년 7월 20일 | $0.0075 |
| 2016년 1월 20일 | $0.0075 |
| 2015년 7월 22일 | $0.0075 |
| 2015년 1월 21일 | $0.0075 |
| 2014년 7월 22일 | $0.0075 |
| 2014년 1월 22일 | $0.0075 |
COO 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
- 적극 매수 6 26.1%
- 매수 7 30.4%
- 보유 10 43.5%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
14 명의 애널리스트 · 2026-08-16실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 6월 30일 | $1.21 | $1.11 | 0.10% |
| 2026년 3월 31일 | $1.10 | $1.04 | 0.06% |
| 2025년 12월 31일 | $1.15 | $1.12 | 0.03% |
| 2025년 9월 30일 | $1.10 | $1.08 | 0.02% |
| 2025년 6월 30일 | $0.96 | $0.94 | 0.02% |
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| MDLN | — | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 16
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Cost of Revenue | $1.41B | $1.30B | $1.24B | $1.17B | $967M | $896M | $897M | $900M | $773M | $794M | $727M | $626M | |
| Gross Profit | $2.68B | $2.60B | $2.36B | $2.14B | $1.96B | $1.53B | $1.76B | $1.63B | $1.37B | $1.17B | $1.07B | $1.09B | |
| R&D Expense | $172M | $155M | $137M | $110M | $93M | $93M | $87M | $85M | $69M | $65M | $70M | $66M | |
| SG&A Expense | $1.63B | $1.53B | $1.50B | $1.34B | $1.21B | $992M | $996M | $973M | $799M | $723M | $712M | $683M | |
| Operating Income | $683M | $706M | $533M | $508M | $506M | $312M | $547M | $403M | $429M | $324M | $237M | $306M | |
| Interest Expense | · | · | $105M | $57M | $23M | $37M | $68M | $83M | $33M | $26M | $18M | $8M | |
| Other Non-op | $-16M | $-9M | $-15M | $25M | $9M | $-8M | $-1M | $12M | $-2M | $-2M | $-3M | $-2M | |
| Pretax Income | $566M | $582M | $413M | $475M | $492M | $266M | $477M | $332M | $394M | $296M | $216M | $296M | |
| Income Tax | $192M | $190M | $119M | $90M | $-2.45B | $28M | $11M | $192M | $21M | $21M | $10M | $25M | |
| Net Income | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| EPS (Basic) | $1.88 | $1.97 | $1.49 | $1.95 | $59.80 | $4.85 | $9.44 | $2.85 | $7.63 | $5.65 | $4.20 | $5.61 | |
| EPS (Diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 | $5.51 | |
| Shares (Basic) | 199,100,000 | 198,900,000 | 197,900,000 | 197,400,000 | 49,200,000 | 49,100,000 | 49,400,000 | 49,100,000 | 48,900,000 | 48,500,000 | 48,500,000 | 48,061,000 | |
| Shares (Diluted) | 200,000,000 | 200,400,000 | 199,300,000 | 198,800,000 | 49,800,000 | 49,600,000 | 50,000,000 | 49,700,000 | 49,600,000 | 49,000,000 | 49,200,000 | 49,000,000 | |
| EBITDA | $1.06B | $1.08B | $901M | $508M | $506M | $312M | $828M | $678M | $618M | $522M | $428M | $445M |
대차대조표 29
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $108M | $121M | $138M | $96M | $116M | $89M | $78M | $89M | $101M | $16M | $25M | |
| Receivables | $829M | $717M | $610M | $558M | $515M | $435M | $435M | $375M | $317M | $291M | $283M | $276M | |
| Inventory | $846M | $803M | $736M | $629M | $586M | $570M | $507M | $469M | $454M | $418M | $420M | $382M | |
| Prepaid Expense | $321M | $324M | $239M | $209M | $179M | $152M | $132M | $170M | $94M | $78M | $81M | $68M | |
| Current Assets | $2.11B | $1.95B | $1.70B | $1.53B | $1.47B | $1.27B | $1.16B | $1.09B | $953M | $937M | $841M | $792M | |
| PP&E (Net) | $2.08B | $1.86B | $1.63B | $1.41B | $1.35B | $1.28B | $1.13B | $976M | $910M | $878M | $967M | $937M | |
| PP&E (Gross) | $3.91B | $3.56B | $3.18B | $2.80B | $2.66B | $2.47B | $2.19B | $1.93B | $1.76B | $1.60B | $1.65B | $1.53B | |
| Accum. Depreciation | $1.83B | $1.70B | $1.55B | $1.39B | $1.31B | $1.19B | $1.06B | $954M | $847M | $726M | $684M | $589M | |
| Goodwill | $3.85B | $3.84B | $3.62B | $3.61B | $2.57B | $2.45B | $2.43B | $2.39B | $2.35B | $2.16B | $2.20B | $2.22B | |
| Intangibles | $1.59B | $1.79B | $1.71B | $1.89B | $1.27B | $1.29B | $1.41B | $1.52B | $505M | $441M | $411M | $454M | |
| Other Non-current Assets | $689M | $661M | $637M | $588M | $401M | $105M | $67M | $74M | $76M | $52M | $39M | $39M | |
| Total Assets | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Accounts Payable | $300M | $260M | $262M | $249M | $161M | $176M | $150M | $146M | $142M | $107M | $117M | $116M | |
| Short-term Debt | $47M | $32M | $44M | $396M | $83M | $409M | $564M | $37M | $23M | $226M | $244M | $102M | |
| Current Liabilities | $1.11B | $1.02B | $969M | $1.28B | $732M | $1.00B | $1.11B | $536M | $396M | $543M | $569M | $442M | |
| Capital Leases | $240M | $231M | $216M | $206M | $232M | $237M | · | · | · | · | · | · | |
| Deferred Tax | $93M | $96M | $102M | $150M | $24M | $26M | $28M | $31M | $39M | $38M | $31M | $70M | |
| Other Non-current Liabilities | $283M | $312M | $239M | $225M | · | · | · | · | · | · | · | · | |
| Total Liabilities | $4.16B | $4.23B | $4.11B | $4.32B | $2.66B | $2.91B | $2.65B | $2.81B | $1.68B | $1.78B | $1.79B | $1.87B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.99B | $1.15B | $1.32B | $1.11B | $1.28B | |
| Total Debt | $2.50B | $2.58B | $2.56B | $2.35B | $1.40B | $1.38B | $1.26B | $2.02B | $1.17B | $1.54B | $1.35B | $1.38B | |
| Common Stock | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.98B | $1.92B | $1.82B | $1.77B | $1.72B | $1.65B | $1.61B | $1.57B | $1.53B | $1.49B | $1.43B | $1.39B | |
| Retained Earnings | $7.64B | $7.27B | $6.88B | $6.58B | $6.20B | $3.26B | $3.03B | $2.58B | $2.43B | $2.05B | $1.78B | $1.58B | |
| Treasury Stock | $995M | $706M | $710M | $714M | $640M | $617M | $571M | $415M | $415M | $360M | $360M | $295M | |
| AOCI | $-406M | $-422M | $-454M | $-467M | $-341M | $-472M | $-447M | $-431M | $-375M | $-490M | $-192M | $-106M | |
| Stockholders' Equity | $8.24B | $8.08B | $7.55B | $7.17B | $6.94B | $3.82B | $3.63B | $3.31B | $3.18B | $2.70B | $2.67B | $2.57B | |
| Liabilities + Equity | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Shares Outstanding | 195,900,000 | 199,600,000 | 198,100,000 | 49,300,000 | 49,300,000 | 49,100,000 | · | · | 48,800,000 | 48,800,000 | 48,300,000 | 48,100,000 |
현금 흐름 18
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $377M | $375M | $368M | $346M | $309M | · | $281M | $275M | $188M | $198M | $191M | $138M | |
| Stock-based Comp | $70M | $75M | $62M | $54M | $44M | $38M | $35M | $43M | $37M | $30M | $33M | $37M | |
| Deferred Tax | $135M | $119M | $45M | $54M | $-2.50B | $-900.0K | $-16M | $3M | $-7M | $-11M | $6M | $-16M | |
| Amort. of Intangibles | $199M | $201M | $186M | $180M | $146M | $137M | $146M | $147M | $68M | $61M | $52M | $36M | |
| Other Non-cash | $-162M | $-252M | $-161M | · | · | · | $-54M | $208M | $2M | $18M | $-42M | $26M | |
| Operating Cash Flow | $796M | $709M | $608M | $692M | $739M | $487M | $713M | $669M | $594M | $510M | $391M | $455M | |
| CapEx | $362M | $421M | $392M | $242M | $214M | $310M | $292M | $194M | $127M | $153M | $243M | $238M | |
| Investing Cash Flow | $-373M | $-765M | $-449M | $-1.83B | $-450M | $-364M | $-351M | $-1.52B | $-381M | $-419M | $-288M | $-1.35B | |
| Debt Issued | $3.11B | $3.52B | $2.12B | $1.51B | $1.43B | $3.20B | $1.14B | $2.75B | $1.41B | $1.58B | $1.20B | $2.56B | |
| Net Debt Issued | $-94M | $17M | $170M | $950M | $12M | $-30M | $-725M | $836M | $49M | $117M | $-171M | $895M | |
| Stock Repurchased | $290M | $0 | $0 | $78M | $25M | $48M | $156M | $0 | $55M | $0 | $67M | $76M | |
| Net Stock Activity | $-290M | $0 | $0 | $-78M | $-25M | $-48M | $-156M | $0 | $-55M | $0 | $-67M | $-76M | |
| Dividends Paid | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Financing Cash Flow | $-426M | $39M | $-174M | $1.19B | $-311M | $-96M | $-351M | $844M | $-228M | $-1M | $-107M | $842M | |
| Net Change in Cash | $3M | $-13M | $-18M | $42M | $-20M | $27M | $9M | $-9M | $-12M | $84M | $-9M | $-52M | |
| Taxes Paid | · | · | · | · | · | · | · | $19M | $16M | $29M | $12M | $16M | |
| Free Cash Flow | $434M | $288M | $215M | $450M | $524M | $176M | $421M | $475M | $466M | $357M | $148M | $217M | |
| Levered FCF | · | · | $140M | $404M | $386M | · | · | $440M | $435M | $333M | $131M | $209M |
수익성 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% | 66.2% | 64.5% | 63.8% | 59.6% | 59.6% | 63.5% | |
| Operating Margin | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% | 20.1% | 16.5% | 13.2% | 17.8% | |
| Net Margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% | 11.3% | 15.7% | |
| Pretax Margin | 13.8% | 14.9% | 11.5% | 14.4% | 16.8% | · | · | 13.1% | 18.4% | 15.0% | 12.0% | 17.3% | |
| EBITDA Margin | 25.9% | 27.8% | 25.1% | 15.3% | 17.3% | 12.8% | 31.2% | 26.8% | 28.9% | 26.6% | 23.8% | 25.9% | |
| ROA | 3.0% | 3.3% | 2.5% | 3.7% | 36.0% | 3.7% | 7.5% | 2.5% | 8.0% | 6.1% | 4.6% | 7.1% | |
| ROE | 4.6% | 5.0% | 4.0% | 5.5% | 54.7% | 6.4% | 13.0% | 4.3% | 12.7% | 10.2% | 7.8% | 10.8% | |
| ROIC | 4.2% | 4.5% | 3.8% | 4.3% | 36.3% | · | · | 3.2% | 9.3% | 7.1% | 5.6% | 7.1% |
유동성 및 지급능력 5
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 | 1.3 | 1.0 | 2.0 | 2.4 | 1.7 | 1.5 | 1.8 | |
| Quick Ratio | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 | 0.5 | 0.5 | 0.8 | 1.0 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.6 | 0.5 | 0.5 | |
| LT Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | 5.1 | 8.9 | 21.9 | 8.5 | 8.0 | 4.9 | 12.8 | 12.4 | 13.1 | 38.5 |
효율성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 | |
| Inventory Turnover | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.7 | 1.8 | 2.0 | 1.8 | 1.9 | 1.8 | 1.7 | |
| Receivables Turnover | 5.3 | 5.9 | 6.2 | 6.2 | 6.1 | 5.6 | 6.6 | 7.3 | 7.0 | 6.8 | 6.4 | 6.8 |
성장률 9
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.1% | 8.4% | 8.6% | 13.2% | 20.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.3% | 10.1% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.6% | 32.4% | -23.7% | -96.7% | 1129.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.2% | -67.9% | -32.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -4.4% | 33.3% | -23.7% | -86.9% | 1135.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -0.95% | -48.9% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
가치 평가 (TTM) 17
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Net Income TTM | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| Market Cap | $13.70B | $20.89B | $3.86B | $3.37B | $5.14B | · | · | · | $2.93B | $2.15B | $1.84B | $1.97B | |
| Enterprise Value | $16.09B | $23.37B | $6.30B | $5.58B | $6.44B | · | · | · | $4.02B | $3.59B | $3.18B | $3.33B | |
| P/E | 37.4 | 53.4 | 52.7 | 35.2 | 1.8 | 16.6 | 7.8 | 23.0 | 8.0 | 7.9 | 9.2 | 7.4 | |
| P/S | 3.3 | 5.4 | 1.1 | 1.0 | 1.8 | · | · | · | 1.4 | 1.1 | 1.0 | 1.1 | |
| P/B | 1.7 | 2.6 | 0.5 | 0.5 | 0.7 | · | · | · | 0.9 | 0.8 | 0.7 | 0.8 | |
| P / Tangible Book | 4.9 | 8.5 | 1.7 | 2.0 | 1.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 17.2 | 29.5 | 6.4 | 4.9 | 7.0 | · | · | · | 4.9 | 4.2 | 4.7 | 4.3 | |
| P / FCF | 31.6 | 72.5 | 17.9 | 7.5 | 9.8 | · | · | · | 6.3 | 6.0 | 12.4 | 9.1 | |
| EV / EBITDA | 15.2 | 21.6 | 7.0 | 11.0 | 12.7 | · | · | · | 6.5 | 6.9 | 7.4 | 7.5 | |
| EV / FCF | 37.1 | 81.1 | 29.3 | 12.4 | 12.3 | · | · | · | 8.6 | 10.1 | 21.5 | 15.4 | |
| EV / Revenue | 3.9 | 6.0 | 1.8 | 1.7 | 2.2 | · | · | · | 1.9 | 1.8 | 1.8 | 1.9 | |
| Dividend Yield | 0.00% | 0.00% | 0.08% | 0.09% | 0.06% | · | · | · | 0.10% | 0.14% | 0.16% | 0.15% | |
| Earnings Yield | 2.7% | 1.9% | 1.9% | 2.8% | 56.8% | 6.0% | 12.8% | 4.3% | 12.5% | 12.7% | 10.9% | 13.5% | |
| Payout Ratio | 0.00% | 0.00% | 1.0% | 0.78% | 0.10% | 1.3% | 0.64% | 2.1% | 0.78% | 1.1% | 1.4% | 1.1% | |
| Annual Payout | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
손익계산서 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.08B | $1.02B | $1.07B | $1.06B | $1.00B | $965M | $1.02B | $1.00B | $943M | $932M | $927M | $930M | $877M | $858M | $848M | $843M | |
| Cost of Revenue | $346M | $329M | $414M | $368M | $323M | $304M | $341M | $340M | $311M | $308M | $321M | $320M | $294M | $300M | $311M | $291M | |
| Gross Profit | $735M | $695M | $651M | $692M | $679M | $660M | $678M | $663M | $631M | $624M | $606M | $610M | $583M | $558M | $537M | $552M | |
| R&D Expense | $42M | $44M | $41M | $45M | $46M | $41M | $38M | $39M | $39M | $40M | $37M | $36M | $33M | $32M | $29M | $29M | |
| SG&A Expense | $676M | $390M | $419M | $422M | $399M | $388M | $391M | $381M | $380M | $381M | $388M | $375M | $408M | $331M | $358M | $343M | |
| Operating Income | $-31M | $213M | $140M | $176M | $185M | $182M | $198M | $192M | $162M | $153M | $136M | $152M | $96M | $150M | $104M | $141M | |
| Interest Expense | · | · | · | · | · | · | · | · | $29M | $30M | · | $27M | $26M | $26M | · | $17M | |
| Other Non-op | $4M | $2M | $800.0K | $2M | $-16M | $-3M | $-3M | $-300.0K | $-3M | $-3M | $-3M | $-6M | $-5M | $-1M | $-8M | $-6M | |
| Pretax Income | $-48M | $192M | $117M | $152M | $144M | $153M | $169M | $164M | $130M | $120M | $106M | $119M | $66M | $122M | $72M | $117M | |
| Income Tax | $30M | $61M | $32M | $54M | $57M | $49M | $51M | $59M | $41M | $39M | $22M | $34M | $26M | $38M | $7M | $19M | |
| Net Income | $-78M | $131M | $85M | $98M | $88M | $104M | $118M | $105M | $89M | $81M | $84M | $85M | $40M | $85M | $66M | $98M | |
| EPS (Basic) | $-0.40 | $0.67 | $0.43 | $0.49 | $0.44 | $0.52 | $0.58 | $0.53 | $0.45 | $0.41 | $0.43 | $0.43 | $0.20 | $0.43 | $-4.54 | $1.99 | |
| EPS (Diluted) | $-0.40 | $0.66 | $0.42 | $0.49 | $0.44 | $0.52 | $0.59 | $0.52 | $0.44 | $0.41 | $0.42 | $0.43 | $0.20 | $0.43 | $-4.50 | $1.98 | |
| Shares (Basic) | 195,000,000 | 195,800,000 | -399,800,000 | 199,300,000 | 199,900,000 | 199,700,000 | -397,500,000 | 199,100,000 | 198,900,000 | 198,400,000 | -395,600,000 | 198,100,000 | 197,900,000 | 197,500,000 | 49,400,000 | 49,300,000 | |
| Shares (Diluted) | 195,000,000 | 196,700,000 | -401,900,000 | 200,000,000 | 200,700,000 | 201,200,000 | -400,600,000 | 200,600,000 | 200,500,000 | 199,900,000 | -398,200,000 | 199,600,000 | 199,200,000 | 198,700,000 | 49,600,000 | 49,600,000 | |
| EBITDA | $-31M | $308M | · | $176M | $185M | $273M | · | $192M | $162M | $250M | · | $152M | $96M | $239M | · | $141M |
대차대조표 28
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $139M | $125M | $111M | $125M | $116M | $101M | $108M | $110M | $112M | $135M | $121M | $117M | $112M | $118M | $138M | $246M | |
| Receivables | $809M | $807M | $829M | $792M | $781M | $716M | $717M | $739M | $689M | $651M | · | $630M | $565M | $582M | · | $544M | |
| Inventory | $896M | $876M | $846M | $881M | $880M | $843M | $803M | $779M | $775M | $748M | · | $724M | $699M | $659M | · | $622M | |
| Prepaid Expense | $455M | $325M | $321M | $340M | $348M | $327M | $324M | $299M | $282M | $260M | · | $240M | $224M | $218M | · | $186M | |
| Current Assets | $2.30B | $2.13B | $2.11B | $2.14B | $2.13B | $1.99B | $1.95B | $1.93B | $1.86B | $1.79B | · | $1.71B | $1.60B | $1.58B | · | $1.60B | |
| PP&E (Net) | · | · | $2.08B | · | · | · | $1.86B | $1.75B | $1.71B | $1.68B | · | $1.53B | $1.49B | $1.46B | · | $1.36B | |
| PP&E (Gross) | · | · | $3.91B | · | · | · | $3.56B | · | · | · | · | · | · | · | · | $2.75B | |
| Accum. Depreciation | · | · | $1.83B | · | · | · | $1.70B | · | · | · | · | · | · | · | · | $1.38B | |
| Goodwill | $3.89B | $3.91B | $3.85B | $3.86B | $3.86B | $3.79B | $3.84B | $3.78B | $3.76B | $3.77B | · | $3.68B | $3.66B | $3.67B | · | $3.67B | |
| Intangibles | $1.49B | $1.54B | $1.59B | $1.64B | $1.69B | $1.74B | $1.79B | $1.79B | $1.80B | $1.85B | · | $1.77B | $1.81B | $1.86B | · | $1.92B | |
| Other Non-current Assets | $673M | $688M | $689M | $653M | $659M | $664M | $661M | $621M | $637M | $617M | · | $628M | $585M | $569M | · | $306M | |
| Total Assets | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | $11.66B | $11.70B | $11.54B | $11.56B | $11.49B | $11.55B | |
| Accounts Payable | $233M | $226M | $300M | $256M | $244M | $202M | $260M | $222M | $231M | $202M | · | $227M | $242M | $224M | · | $227M | |
| Short-term Debt | $598M | $620M | $47M | $46M | $59M | $48M | $32M | $40M | $41M | $45M | · | $63M | $58M | $52M | · | $535M | |
| Current Liabilities | $1.80B | $1.60B | $1.11B | $1.01B | $1.01B | $1000M | $1.02B | $970M | $952M | $965M | · | $994M | $949M | $916M | · | $1.38B | |
| Capital Leases | · | · | $240M | · | · | · | $231M | · | · | · | · | · | · | · | · | $216M | |
| Deferred Tax | $96M | $96M | $93M | $102M | $99M | $95M | $96M | $95M | $94M | $90M | · | $138M | $139M | $144M | · | $144M | |
| Other Non-current Liabilities | $266M | $277M | $283M | $263M | $274M | $261M | $312M | $277M | $278M | $281M | · | · | · | · | · | · | |
| Total Liabilities | $4.24B | $4.06B | $4.16B | $4.02B | $4.13B | $4.09B | $4.23B | $4.18B | $4.24B | $4.34B | · | $4.17B | $4.16B | $4.23B | · | $4.47B | |
| Total Debt | $2.46B | $2.50B | · | $2.48B | $2.58B | $2.54B | · | $2.63B | $2.71B | $2.77B | · | $2.57B | $2.62B | $2.68B | · | $2.88B | |
| Common Stock | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | · | $5M | $5M | $5M | · | $5M | |
| Paid-in Capital | $1.98B | $1.99B | $1.98B | $1.96B | $1.94B | $1.93B | $1.92B | $1.88B | $1.87B | $1.85B | · | $1.82B | $1.80B | $1.78B | · | $1.75B | |
| Retained Earnings | $7.70B | $7.77B | $7.64B | $7.56B | $7.46B | $7.37B | $7.27B | $7.15B | $7.05B | $6.96B | · | $6.79B | $6.71B | $6.67B | · | $6.52B | |
| Treasury Stock | $1.10B | $1.09B | $995M | $796M | $745M | $705M | $706M | $707M | $708M | $709M | · | $711M | $712M | $713M | · | $716M | |
| AOCI | $-363M | $-334M | $-406M | $-392M | $-392M | $-490M | $-422M | $-425M | $-423M | $-422M | · | $-375M | $-424M | $-404M | · | $-477M | |
| Stockholders' Equity | $8.24B | $8.36B | $8.24B | $8.35B | $8.29B | $8.13B | $8.08B | $7.92B | $7.80B | $7.70B | · | $7.53B | $7.38B | $7.34B | · | $7.08B | |
| Liabilities + Equity | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | · | $11.70B | $11.54B | $11.56B | · | $11.55B | |
| Shares Outstanding | 194,900,000 | 195,100,000 | 195,900,000 | 198,800,000 | 199,500,000 | 199,900,000 | 199,600,000 | 199,100,000 | 199,100,000 | 198,700,000 | · | 49,500,000 | 49,500,000 | 49,400,000 | · | 49,300,000 |
현금 흐름 16
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $95M | $96M | $98M | $95M | $93M | $91M | $91M | $89M | $98M | $97M | $93M | $94M | $91M | $90M | $89M | $82M | |
| Deferred Tax | $44M | $44M | $13M | $44M | $44M | $35M | $22M | $36M | $32M | $29M | · | · | · | · | $-1M | $19M | |
| Amort. of Intangibles | $48M | $48M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $46M | $47M | $46M | $46M | $46M | $40M | |
| Other Non-cash | · | $-45M | · | · | · | $-115M | · | · | · | $-165M | · | · | · | $-36M | · | · | |
| Operating Cash Flow | $183M | $261M | $248M | $261M | $96M | $191M | $268M | $208M | $111M | $123M | $174M | $142M | $124M | $167M | $131M | $264M | |
| CapEx | $86M | $102M | $98M | $97M | $78M | $89M | $140M | $89M | $74M | $118M | $145M | $91M | $74M | $83M | $95M | $47M | |
| Investing Cash Flow | $-90M | $-103M | $-99M | $-98M | $-79M | $-97M | $-242M | $-124M | $-75M | $-324M | $-161M | $-93M | $-82M | $-113M | $-100M | $-46M | |
| Debt Issued | $858M | $875M | $936M | $756M | $749M | $670M | $716M | $1.40B | $608M | $795M | $472M | $453M | $497M | $702M | $12M | $-4M | |
| Net Debt Issued | · | $-29M | · | · | · | $-59M | · | · | · | $202M | · | · | · | $276M | · | · | |
| Stock Repurchased | $16M | $92M | $197M | $53M | $41M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | $-92M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | · | · | · | · | · | · | $0 | $0 | · | · | $2M | $0 | · | · | $2M | $0 | |
| Financing Cash Flow | $-76M | $-148M | $-164M | $-156M | $-9M | $-97M | $-28M | $-88M | $-57M | $212M | $-6M | $-43M | $-47M | $-78M | $-134M | $-369M | |
| Net Change in Cash | $14M | $14M | $-14M | $9M | $15M | $-7M | $-2M | $-3M | $-23M | $14M | $3M | $5M | $-6M | $-20M | $-108M | $-153M | |
| Free Cash Flow | · | $159M | · | · | · | $101M | · | · | · | $5M | · | · | · | $84M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-16M | · | · | · | $66M | · | · |
수익성 8
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.0% | 67.9% | · | 65.3% | 67.8% | 68.4% | · | 66.1% | 67.0% | 67.0% | · | 65.6% | 66.4% | 65.1% | · | 65.5% | |
| Operating Margin | -2.9% | 20.8% | · | 16.6% | 18.4% | 18.9% | · | 19.2% | 17.2% | 16.4% | · | 16.3% | 11.0% | 17.4% | · | 16.7% | |
| Net Margin | -7.2% | 12.8% | · | 9.3% | 8.8% | 10.8% | · | 10.4% | 9.4% | 8.7% | · | 9.2% | 4.5% | 9.8% | · | 11.7% | |
| Pretax Margin | -4.5% | 18.8% | · | 14.3% | 14.4% | 15.9% | · | 16.3% | 13.8% | 12.9% | · | 12.8% | 7.5% | 14.2% | · | 13.9% | |
| EBITDA Margin | -2.9% | 30.1% | · | 16.6% | 18.4% | 28.3% | · | 19.2% | 17.2% | 26.8% | · | 16.3% | 11.0% | 27.9% | · | 16.7% | |
| ROA | -0.63% | 1.1% | · | 0.80% | 0.72% | 0.86% | · | 0.88% | 0.75% | 0.69% | · | 0.73% | 0.34% | 0.73% | · | 0.93% | |
| ROE | -0.94% | 1.6% | · | 1.2% | 1.1% | 1.3% | · | 1.4% | 1.2% | 1.1% | · | 1.2% | 0.55% | 1.2% | · | 1.4% | |
| ROIC | -0.47% | 1.3% | · | 1.1% | 1.0% | 1.2% | · | 1.2% | 1.1% | 0.99% | · | 1.1% | 0.58% | 1.0% | · | 1.2% |
유동성 및 지급능력 5
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | · | 2.1 | 2.1 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 1.7 | 1.7 | 1.7 | · | 1.2 | |
| Quick Ratio | 0.5 | 0.6 | · | 0.9 | 0.9 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.8 | · | 0.6 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 5.6 | 5.1 | · | 5.7 | 3.7 | 5.7 | · | 8.2 |
효율성 3
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 1.4 | 1.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.6 |
가치 평가 (TTM) 14
| 지표 | 추세 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.17B | $4.05B | · | $4.03B | $3.91B | $3.84B | · | $3.81B | $3.68B | $3.60B | · | $3.51B | $3.41B | $3.32B | · | $3.22B | |
| Net Income TTM | $239M | $421M | · | $395M | $386M | $379M | · | $360M | $295M | $291M | · | $308M | $349M | $405M | · | $936M | |
| Market Cap | $12.26B | $15.81B | · | $14.05B | $16.29B | $19.30B | · | $18.58B | $17.73B | $18.53B | · | $4.84B | $4.72B | $4.31B | · | $4.03B | |
| Enterprise Value | $14.58B | $18.18B | · | $16.40B | $18.76B | $21.74B | · | $21.10B | $20.33B | $21.16B | · | $7.30B | $7.23B | $6.87B | · | $6.67B | |
| P/E | 52.9 | 38.4 | · | 35.9 | 42.5 | 51.1 | · | 51.9 | 60.2 | 63.4 | · | 32.2 | 18.5 | 12.7 | · | 4.3 | |
| P/S | 2.9 | 3.9 | · | 3.5 | 4.2 | 5.0 | · | 4.9 | 4.8 | 5.2 | · | 1.4 | 1.4 | 1.3 | · | 1.3 | |
| P/B | 1.5 | 1.9 | · | 1.7 | 2.0 | 2.4 | · | 2.3 | 2.3 | 2.4 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| P / Tangible Book | 4.3 | 5.4 | · | 4.9 | 6.0 | 7.4 | · | 7.9 | 7.9 | 8.9 | · | 2.3 | 2.5 | 2.4 | · | 2.7 | |
| P / Cash Flow | · | 60.6 | · | · | · | 101.3 | · | · | · | 151.0 | · | · | · | 25.9 | · | · | |
| P / FCF | · | 99.6 | · | · | · | 190.7 | · | · | · | 4028.3 | · | · | · | 51.5 | · | · | |
| EV / EBITDA | -470.3 | 59.0 | · | 93.4 | 101.5 | 79.6 | · | 109.6 | 125.7 | 84.7 | · | 48.1 | 75.1 | 28.7 | · | 47.4 | |
| EV / FCF | · | 114.6 | · | · | · | 214.8 | · | · | · | 4600.7 | · | · | · | 82.1 | · | · | |
| EV / Revenue | 3.5 | 4.5 | · | 4.1 | 4.8 | 5.7 | · | 5.5 | 5.5 | 5.9 | · | 2.1 | 2.1 | 2.1 | · | 2.1 | |
| Earnings Yield | 1.9% | 2.6% | · | 2.8% | 2.4% | 2.0% | · | 1.9% | 1.7% | 1.6% | · | 3.1% | 5.4% | 7.9% | · | 23.0% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| 매출 | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| 매출 총이익률 % | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% |
| 영업이익률 % | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% |
| 순이익 | $375M | $392M | $294M | $386M | $2.94B |
| 희석 EPS | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 |
대차대조표
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| 부채 / 자기자본 비율 | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
| 유동비율 | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 |
| 당좌 비율 | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 |
현금 흐름
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $434M | $288M | $215M | $450M | $524M |
최신 뉴스 이 회사 관련 최근 헤드라인
트레이딩 시그널 진입 가격 및 위험/보상 비율을 포함한 최근 매수/매도 신호
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 743개의 제출자 · $9.7B 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 118 (+10 이전 분기 대비) | 94 (+10 이전 분기 대비) | 244 (+11 이전 분기 대비) | 233 (-4 이전 분기 대비) | +36.4M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $914,931,325 | 12,758,769 | 9.43% | 주식 |
| STATE STREET CORP | $637,691,430 | 8,892,643 | 6.57% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $621,703,470 | 8,669,690 | 6.41% | 주식 |
| BROWNING WEST LP | $515,984,142 | 7,195,428 | 5.32% | 주식 |
| GENERATION INVESTMENT MANAGEMENT LLP | $356,303,541 | 4,968,673 | 3.67% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $337,031,684 | 4,720,661 | 3.47% | 주식 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $287,152,440 | 4,004,357 | 2.96% | 주식 |
| Longview Partners (Guernsey) LTD | $282,537,902 | 3,940,007 | 2.91% | 주식 |
| CITADEL ADVISORS LLC | $277,086,436 | 3,863,986 | 2.86% | 주식 |
| JANA Partners Management, LP | $256,899,641 | 3,582,480 | 2.65% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $214,288,268 | 2,988,262 | 2.21% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $211,804,736 | 2,953,629 | 2.18% | 주식 |
| LONDON CO OF VIRGINIA | $207,821,082 | 2,898,075 | 2.14% | 주식 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $195,854,209 | 2,731,198 | 2.02% | 주식 |
| River Road Asset Management, LLC | $142,048,546 | 1,980,875 | 1.46% | 주식 |
| Sustainable Growth Advisers, LP | $139,368,026 | 1,943,495 | 1.44% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $132,231,017 | 1,843,969 | 1.36% | 주식 |
| Gates Capital Management, Inc. | $121,088,717 | 1,688,589 | 1.25% | 주식 |
| Alecta Tjanstepension Omsesidigt | $112,082,730 | 1,563,000 | 1.16% | 주식 |
| BARCLAYS PLC | $108,118,888 | 1,507,724 | 1.11% | 주식 |
| MANNING & NAPIER ADVISORS LLC | $107,938,609 | 1,505,210 | 1.11% | 주식 |
| Focus Partners Wealth | $101,143,265 | 1,410,461 | 1.04% | 주식 |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $100,125,518 | 1,396,256 | 1.03% | 주식 |
| Findlay Park Partners LLP | $92,075,640 | 1,284,000 | 0.95% | 주식 |
| BANK OF AMERICA CORP /DE/ | $85,233,287 | 1,188,583 | 0.88% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $78,580,965 | 1,095,816 | 0.81% | 주식 |
| Holocene Advisors, LP | $77,495,348 | 1,080,677 | 0.80% | 주식 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $72,342,127 | 1,011,778 | 0.75% | 주식 |
| Balyasny Asset Management L.P. | $71,022,946 | 990,419 | 0.73% | 주식 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $69,128,942 | 964,007 | 0.71% | 주식 |
| ENVESTNET ASSET MANAGEMENT INC | $63,808,602 | 889,815 | 0.66% | 주식 |
| STOREBRAND ASSET MANAGEMENT AS | $56,153,519 | 783,064 | 0.58% | 주식 |
| HARRIS ASSOCIATES L P | $54,967,149 | 766,520 | 0.57% | 주식 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $52,710,220 | 735,047 | 0.54% | 주식 |
| NORGES BANK | $52,378,920 | 730,427 | 0.54% | 주식 |
| Quantinno Capital Management LP | $47,268,411 | 659,160 | 0.49% | 주식 |
| DAVENPORT & Co LLC | $44,161,791 | 617,390 | 0.46% | 주식 |
| RAYMOND JAMES FINANCIAL INC | $43,870,959 | 611,783 | 0.45% | 주식 |
| Capital World Investors | $42,389,789 | 591,128 | 0.44% | 주식 |
| TD Asset Management Inc | $40,340,389 | 562,549 | 0.42% | 주식 |
| GOLDMAN SACHS GROUP INC | $39,475,710 | 550,491 | 0.41% | 주식 |
| Swiss National Bank | $39,462,013 | 550,300 | 0.41% | 주식 |
| FMR LLC | $38,283,244 | 533,862 | 0.39% | 주식 |
| Assenagon Asset Management S.A. | $37,710,281 | 525,872 | 0.39% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $36,228,466 | 505,208 | 0.37% | 주식 |
| VANGUARD GROUP INC | $35,623,996 | 434,651 | 0.37% | 주식 |
| JONES FINANCIAL COMPANIES LLLP | $34,958,672 | 492,237 | 0.36% | 주식 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $34,732,165 | 484,342 | 0.36% | 주식 |
| Sumitomo Mitsui Trust Group, Inc. | $31,878,681 | 444,550 | 0.33% | 주식 |
| CRAMER ROSENTHAL MCGLYNN LLC | $31,864,984 | 444,359 | 0.33% | 주식 |
| HBK INVESTMENTS L P | $31,666,377 | 441,651 | 0.33% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $31,217,873 | 435,335 | 0.32% | 주식 |
| Champlain Investment Partners, LLC | $30,908,803 | 431,025 | 0.32% | 주식 |
| BAMCO INC /NY/ | $30,683,848 | 427,888 | 0.32% | 주식 |
| Vanguard Global Advisers, LLC | $30,491,881 | 425,211 | 0.31% | 주식 |
| CI INVESTMENTS INC. | $30,192,492 | 421,036 | 0.31% | 주식 |
| Susquehanna Portfolio Strategies, LLC | $30,114,830 | 419,953 | 0.31% | 주식 |
| Rathbones Group PLC | $29,369,475 | 409,559 | 0.30% | 주식 |
| VANGUARD ASSET MANAGEMENT, Ltd | $28,555,137 | 398,203 | 0.29% | 주식 |
| BlackRock, Inc. | $27,878,553 | 388,768 | 0.29% | 주식 |
| Sone Capital Management, LLC | $27,753,921 | 387,030 | 0.29% | 주식 |
| RHUMBLINE ADVISERS | $27,647,083 | 385,541 | 0.28% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $27,579,164 | 384,593 | 0.28% | 주식 |
| UBS Group AG | $24,922,811 | 347,550 | 0.26% | 주식 |
| NEUBERGER BERMAN GROUP LLC | $24,912,915 | 347,412 | 0.26% | 주식 |
| WESTWOOD HOLDINGS GROUP INC | $24,817,325 | 346,079 | 0.26% | 주식 |
| Gotham Asset Management, LLC | $24,697,067 | 344,402 | 0.25% | 주식 |
| California Public Employees Retirement System | $24,485,810 | 341,456 | 0.25% | 주식 |
| ASSETMARK, INC | $23,939,488 | 333,838 | 0.25% | 주식 |
| NOMURA HOLDINGS INC | $22,887,824 | 319,172 | 0.24% | 주식 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $22,435,556 | 313,784 | 0.23% | 주식 |
| Woodline Partners LP | $21,808,875 | 304,126 | 0.22% | 주식 |
| Triodos Investment Management BV | $21,477,145 | 299,500 | 0.22% | 주식 |
| FIRST TRUST ADVISORS LP | $20,079,166 | 280,006 | 0.21% | 주식 |
| Trajan Wealth LLC | $19,347,573 | 269,803 | 0.20% | 주식 |
| Ruffer LLP | $19,239,619 | 268,591 | 0.20% | 주식 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $18,969,088 | 264,525 | 0.20% | 주식 |
| MARSHALL WACE, LLP | $18,353,386 | 255,939 | 0.19% | 주식 |
| Estuary Capital Management LP | $18,092,433 | 252,300 | 0.19% | 주식 |
| Eurizon Capital SGR S.p.A. | $17,361,572 | 242,170 | 0.18% | 주식 |
| HSBC HOLDINGS PLC | $17,306,086 | 241,368 | 0.18% | 주식 |
| Boston Trust Walden Corp | $16,741,417 | 233,460 | 0.17% | 주식 |
| OSSIAM | $16,681,180 | 232,620 | 0.17% | 주식 |
| PRINCIPAL FINANCIAL GROUP INC | $16,202,875 | 225,950 | 0.17% | 주식 |
| TAURUS ASSET MANAGEMENT, LLC | $16,182,885 | 191,854 | 0.17% | 주식 |
| Soapstone Management L.P. | $16,134,750 | 225,000 | 0.17% | 주식 |
| ROYCE & ASSOCIATES LP | $16,054,363 | 223,879 | 0.17% | 주식 |
| PFM Health Sciences, LP | $15,840,022 | 220,890 | 0.16% | 주식 |
| SHAPIRO CAPITAL MANAGEMENT LLC | $15,087,784 | 210,400 | 0.16% | 주식 |
| STIFEL FINANCIAL CORP | $14,726,022 | 205,355 | 0.15% | 주식 |
| HEARTLAND ADVISORS INC | $14,616,936 | 203,834 | 0.15% | 주식 |
| CIBC WORLD MARKETS CORP | $14,560,604 | 177,655 | 0.15% | 주식 |
| ALLIANCEBERNSTEIN L.P. | $14,355,484 | 200,776 | 0.15% | 주식 |
| Bellevue Group AG | $14,136,551 | 197,135 | 0.15% | 주식 |
| Point72 (DIFC) Ltd | $14,092,165 | 205,545 | 0.15% | 주식 |
| STATE OF WISCONSIN INVESTMENT BOARD | $14,090,298 | 196,490 | 0.15% | 주식 |
| BROWN ADVISORY INC | $13,759,715 | 191,880 | 0.14% | 주식 |
| SEB Asset Management AB | $13,427,318 | 187,245 | 0.14% | 주식 |
| Legal & General Group Plc | $13,292,093 | 185,359 | 0.14% | 주식 |
| Engineers Gate Manager LP | $13,281,481 | 185,211 | 0.14% | 주식 |
회사 내부자 45 명의 내부자 · 22 임원 · 17 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| REMMELL PAUL L | Pres & CEO - CooperSurgical | 2017년 7월 14일 M | 1,352 | 0 | 0 | $0 |
| Nicholas J Pichotta | Pres, CEO Cooper Medical, Inc. | 2014년 1월 8일 M | 10,697 | 0 | 0 | $0 |
| Brian G Andrews | SVP, CFO & Treasurer | 2019년 3월 25일 S | 1,101 | 0 | 0 | $0 |
| Gregory W Matz | SVP, CFO & CRO | 2016년 6월 13일 M | 15,123 | 0 | 0 | $0 |
| Steven M Neil | EVP & CFO | 2008년 1월 16일 P | 4,300 | 0 | 0 | $0 |
| John J Calcagno | CFO - CooperVision | 2007년 10월 25일 A | 0 | 0 | 0 | $0 |
| Robert D Auerbach | President, CSI | 2019년 4월 1일 M | 2,538 | 0 | 0 | $0 |
| John Arthur Weber | President, CooperVision, Inc. | 2014년 1월 8일 M | 15,260 | 0 | 0 | $0 |
| Dennis Murphy | President Americas, CVI | 2009년 9월 11일 M | 0 | 0 | 0 | $0 |
| Gregory A Fryling | Pres & COO - CVI | 2006년 10월 24일 A | 3,790 | 0 | 0 | $0 |
| Agostino Ricupati | SVP & CAO | 2024년 4월 1일 M | 4,818 | 0 | 0 | $0 |
| Randal Golden | VP, General Counsel & Sec. | 2019년 6월 19일 S | 1,148 | 0 | 0 | $0 |
| Holly R Sheffield | EVP, CSO | 2018년 12월 11일 A | — | 0 | 0 | $0 |
| Carol R Kaufman | EVP, Sec. & Chief Gov. Officer | 2018년 4월 11일 G | 45,898 | 0 | 0 | $0 |
| Tina Maloney | VP, Corporate Controller | 2017년 1월 8일 M | 2,874 | 0 | 0 | $0 |
| Rodney Folden | VP & Corporate Controller | 2014년 1월 8일 M | 8,592 | 0 | 0 | $0 |
| Eugene J Midlock | VP Tax | 2012년 1월 9일 M | 2,137 | 0 | 0 | $0 |
| Jeffrey Alan Mclean | Exec VP, Comm. Strategies-CVI | 2008년 12월 11일 A | 0 | 0 | 0 | $0 |
| Christopher J Marmo | VP, R&D of CooperVision, Inc. | 2006년 10월 24일 A | — | 0 | 0 | $0 |
| Norris B Battin | VP, Investor Relations | 2006년 10월 24일 A | 4,000 | 0 | 0 | $0 |
| David Acosta | Treasurer | 2005년 4월 8일 S | 10,000 | 0 | 0 | $0 |
| Stephen Whiteford | VP, Corporate Controller | 2004년 1월 20일 M | 15,052 | 0 | 0 | $0 |
| Keel Paul A | 이사 | 2026년 7월 1일 A | — | 0 | 0 | $0 |
| Robert S Weiss | 이사 | 2026년 4월 1일 A | 292,599 | 0 | 0 | $0 |
| MADDEN TERESA S | 이사 | 2026년 4월 1일 A | 15,679 | 0 | 0 | $0 |
| Allan E Rubenstein | 이사 | 2019년 9월 12일 S | 3,091 | 0 | 0 | $0 |
| Jody S Lindell | 이사 | 2019년 6월 24일 M | 12,554 | 0 | 0 | $0 |
| Gary S Petersmeyer | 이사 | 2019년 6월 17일 S | 1,588 | 0 | 0 | $0 |
| Michael Kalkstein | 이사 | 2019년 6월 6일 M | 6,338 | 0 | 0 | $0 |
| Colleen Jay | 이사 | 2019년 5월 21일 A | 3,658 | 0 | 0 | $0 |
| William A Kozy | 이사 | 2019년 5월 21일 A | 3,928 | 0 | 0 | $0 |
| Thomas A Bender | 이사 | 2019년 5월 21일 A | 12,952 | 0 | 0 | $0 |
| Stanley Zinberg MD | 이사 | 2019년 3월 12일 M | 10,528 | 0 | 0 | $0 |
| Steven Rosenberg | 이사 | 2016년 1월 5일 A | 12,359 | 0 | 0 | $0 |
| Donald Press | 이사 | 2014년 1월 7일 A | 43,970 | 0 | 0 | $0 |
| Moses Marx | 이사 | 2009년 12월 1일 A | 107,532 | 0 | 0 | $0 |
| FRUTH JOHN D | 이사 | 2008년 1월 14일 A | 6,500 | 0 | 0 | $0 |
| Edgar J Cummins | 이사 | 2005년 12월 27일 S | 1,764 | 0 | 0 | $0 |
| COOPER COMPANIES INC | 이사 | 2004년 11월 1일 A | — | 0 | 0 | $0 |
| Lawrence E. Kurzius | — | 2026년 4월 1일 A | 11,099 | 2 | 0 | $301,780 |
| Cynthia L Lucchese | — | 2026년 4월 1일 A | 12,767 | 1 | 0 | $149,963 |
| Daniel G Mcbride | — | 2026년 1월 8일 M | 69,352 | 0 | 0 | $0 |
| Albert G White III | — | 2024년 12월 10일 A | 245,072 | 1 | 0 | $808,000 |
| Andrew Sedgwick | — | 2009년 9월 30일 M | 0 | 0 | 0 | $0 |
| James M Welch | — | 2005년 10월 27일 A | 0 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 143 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2.53% | 17,664 NS | 2026년 4월 30일 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2.24% | 55,341 SH | 2026년 8월 8일 | 일간 |
| EQTY · Valued Advisers Trust | 1.94% | 404,353 NS | 2026년 4월 30일 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.66% | 175,209 SH | 2026년 8월 8일 | 일간 |
| TMFM · RBB Fund, Inc. | 1.54% | 29,422 NS | 2026년 5월 31일 | N-PORT |
| CSMD · Professionally Managed Portfolios | 1.25% | 85,861 NS | 2026년 4월 30일 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.14% | 158,790 NS | 2026년 4월 30일 | N-PORT |
| NUMV · Nushares ETF Trust | 1.02% | 69,990 NS | 2026년 4월 30일 | N-PORT |
| BSMQ · Invesco Exchange-Traded Self-Indexe… | 0.70% | 1,880,000 | 2026년 8월 8일 | 일간 |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0.70% | 111,300 SH | 2026년 8월 8일 | 일간 |
| CGMM · Capital Group Equity ETF Trust I | 0.36% | 164,570 NS | 2026년 5월 31일 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0.31% | 63,124 NS | 2026년 4월 30일 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0.30% | 2,841,101 SH | 2026년 8월 8일 | 일간 |
| ISCV · iShares Trust | 0.27% | 25,490 SH | 2026년 8월 8일 | 일간 |
| IYH · iShares Trust | 0.23% | 116,753 SH | 2026년 8월 8일 | 일간 |
| SIZE · iShares Trust | 0.23% | 13,474 SH | 2026년 8월 8일 | 일간 |
| SCHM · SCHWAB STRATEGIC TRUST | 0.22% | 530,369 NS | 2026년 5월 31일 | N-PORT |
| ISCB · iShares Trust | 0.22% | 8,750 SH | 2026년 8월 8일 | 일간 |
| BSMU · Invesco Exchange-Traded Self-Indexe… | 0.21% | 545,000 | 2026년 8월 8일 | 일간 |
| EVUS · iShares Trust | 0.21% | 10,920 SH | 2026년 8월 8일 | 일간 |
| EUSA · iShares, Inc. | 0.21% | 55,200 SH | 2026년 8월 8일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.21% | 586,725 SH | 2026년 8월 8일 | 일간 |
| RSP · Invesco Exchange-Traded Fund Trust | 0.21% | 2,739,985 SH | 2026년 8월 8일 | 일간 |
| FHLC · FIDELITY COVINGTON TRUST | 0.20% | 90,338 NS | 2026년 4월 30일 | N-PORT |
| ISCG · iShares Trust | 0.18% | 24,891 SH | 2026년 8월 8일 | 일간 |
| IXJ · iShares Trust | 0.18% | 102,346 SH | 2026년 8월 8일 | 일간 |
| CURE · Direxion Shares ETF Trust | 0.18% | 3,907 NS | 2026년 4월 30일 | N-PORT |
| RXL · ProShares Trust | 0.17% | 2,044 NS | 2026년 5월 31일 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.17% | 4,474,789 SH | 2026년 8월 8일 | 일간 |
| NBCR · Neuberger Berman ETF Trust | 0.16% | 23,148 NS | 2026년 5월 31일 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0.15% | 3,340 NS | 2026년 4월 30일 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0.14% | 34,363 NS | 2026년 4월 30일 | N-PORT |
| IWS · iShares Trust | 0.14% | 294,321 SH | 2026년 8월 8일 | 일간 |
| APUE · Trust for Professional Managers | 0.13% | 55,777 NS | 2026년 5월 31일 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0.13% | 8,292 NS | 2026년 5월 31일 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.11% | 235,114 NS | 2026년 4월 30일 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.11% | 7,335 NS | 2026년 4월 30일 | N-PORT |
| BSMT · Invesco Exchange-Traded Self-Indexe… | 0.10% | 270,000 | 2026년 8월 8일 | 일간 |
| IWR · iShares Trust | 0.10% | 792,812 SH | 2026년 8월 8일 | 일간 |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 11,432 SH | 2026년 8월 8일 | 일간 |
| BSMS · Invesco Exchange-Traded Self-Indexe… | 0.08% | 255,000 | 2026년 8월 8일 | 일간 |
| VLUE · iShares Trust | 0.08% | 104,586 SH | 2026년 8월 8일 | 일간 |
| XOEF · iShares Trust | 0.08% | 245 SH | 2026년 8월 8일 | 일간 |
| CAPE · DoubleLine ETF Trust | 0.07% | 2,453 NS | 2026년 3월 31일 | N-PORT |
| BSMR · Invesco Exchange-Traded Self-Indexe… | 0.06% | 215,000 | 2026년 8월 8일 | 일간 |
| BAB · Invesco Exchange-Traded Fund Trust … | 0.06% | 582,000 | 2026년 8월 8일 | 일간 |
| VFVA · VANGUARD WELLINGTON FUND | 0.06% | 7,148 SH | 2026년 8월 8일 | 일간 |
| JSTC · Tidal Trust I | 0.05% | 3,001 NS | 2026년 5월 31일 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0.05% | 44,755 SH | 2026년 8월 8일 | 일간 |
| IVE · iShares Trust | 0.05% | 324,351 SH | 2026년 8월 8일 | 일간 |